Revvity (RVTY) Net Income towards Common Stockholders Growth (1y) (2010 - 2026)
Revvity (RVTY) Net Income towards Common Stockholders Growth (1y) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.70 Bn | 209.63 Bn | 8.34 Bn | 8.66% |
| 2 | Danaher | 140.15 Bn | 135.80 Bn | 3.61 Bn | 56.76% |
| 3 | Idexx Laboratories | 46.31 Bn | 46.11 Bn | 779.09 Mn | 15.11% |
| 4 | Agilent Technologies | 39.74 Bn | 37.93 Bn | 990.00 Mn | 57.67% |
| 5 | Iqvia Holdings | 39.38 Bn | 37.30 Bn | 1.44 Bn | -9.74% |
| 6 | Natera | 38.78 Bn | 37.68 Bn | 696.04 Mn | -27.15% |
| 7 | Illumina | 29.96 Bn | 28.79 Bn | 770.00 Mn | -11.91% |
| 8 | Mettler Toledo International | 28.60 Bn | 28.55 Bn | 650.22 Mn | 15.10% |
| 9 | Quest Diagnostics | 26.26 Bn | 25.64 Bn | 1.03 Bn | 12.89% |
| 10 | Revvity | 12.81 Bn | 11.95 Bn | 387.66 Mn | -130.81% |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 5, 2026 | -130.81% |
| Dec 28, 2025 | -58.59% |
| Sep 28, 2025 | -158.00% |
| Jun 29, 2025 | 92.61% |
| Mar 30, 2025 | 121.17% |
| Sep 29, 2024 | 104.27% |
| Jun 30, 2024 | 25.22% |
| Mar 31, 2024 | -100.49% |
| Oct 1, 2023 | -245.03% |
| Jul 2, 2023 | -230.96% |
| Apr 2, 2023 | 7,762.21% |
| Jan 1, 2023 | 394.85% |
| Oct 2, 2022 | -21.23% |
| Jul 3, 2022 | -2.56% |
| Apr 3, 2022 | -175.25% |
| Jan 2, 2022 | 8,449.32% |
| Oct 3, 2021 | 54,443.24% |
| Apr 4, 2021 | 18,992.00% |
| Jan 3, 2021 | -52.08% |
| Oct 4, 2020 | 28.85% |